Literature DB >> 12618492

Chemotherapy for elderly patients with advanced non-small-cell lung cancer.

Paul A Bunn, Rogerio Lilenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618492     DOI: 10.1093/jnci/95.5.341

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

1.  Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  Lung Cancer       Date:  2016-05-31       Impact factor: 5.705

2.  Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.

Authors:  Jarrod T Bullard; Jan M Eberth; Amanda K Arrington; Swann A Adams; Xi Cheng; Ramzi G Salloum
Journal:  South Med J       Date:  2017-02       Impact factor: 0.954

3.  Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.

Authors:  C L Baunemann Ott; N Ratna; R Prayag; Z Nugent; K Badiani; S Navaratnam
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

4.  Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience.

Authors:  U Kefeli; S Kaya; B O Ustaalioglu; A Bilici; A U Kefeli; M E Yildirim; M Seker; B Yilmaz; T Salepci; K Uygun; M Gumus
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

5.  Factors affecting recovery of functional status in older adults after cancer surgery.

Authors:  Janet H Van Cleave; Brian L Egleston; Ruth McCorkle
Journal:  J Am Geriatr Soc       Date:  2010-12-16       Impact factor: 5.562

6.  Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.

Authors:  M C Pietanza; Matthew D Hellmann; John J Fiore; Stephanie Smith-Marrone; Ethan M Basch; Lawrence H Schwartz; Michelle S Ginsberg; Marwan Shouery; Samantha K Newman; Mary Shaw; Lauren J Rogak; Alex E Lash; Patrick Hilden; Mark G Kris
Journal:  J Thorac Oncol       Date:  2016-03-08       Impact factor: 15.609

7.  Combining extant datasets with differing outcome measures across studies of older adults after cancer surgery.

Authors:  Janet H Van Cleave; Brian L Egleston; Meg Bourbonniere; Ruth McCorkle
Journal:  Res Gerontol Nurs       Date:  2010-12-29       Impact factor: 1.571

8.  Epidermal growth factor receptor-tyrosine kinase inhibitors for non-small-cell lung cancer patients aged 80 years or older: A retrospective analysis.

Authors:  Makoto Nakao; Hideki Muramatsu; Kazuki Sone; Sachiko Aoki; Harata Akiko; Yusuke Kagawa; Hidefumi Sato; Takefumi Kunieda
Journal:  Mol Clin Oncol       Date:  2014-11-05

9.  A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901.

Authors:  Riichiroh Maruyama; Noriyuki Ebi; Junji Kishimoto; Masato Kato; Tokujiro Yano; Yoshinori Nagamatsu; Shuichi Tsukamoto; Shinji Akamine; Sho Saeki; Yukito Ichinose
Journal:  Int J Clin Oncol       Date:  2013-01-26       Impact factor: 3.402

Review 10.  Docetaxel in non-small cell lung cancer: impact on quality of life and pharmacoeconomics.

Authors:  Leora Horn; Antonio Visbal; Natasha B Leighl
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.